Prestige Consumer Healthcare
PBH
#3940
Rank
NZ$5.18 B
Marketcap
NZ$105.28
Share price
1.27%
Change (1 day)
-27.11%
Change (1 year)

Prestige Consumer Healthcare (PBH) - Total debt

Total debt on the balance sheet as of September 2025 : NZ$1.80 Billion

According to Prestige Consumer Healthcare's latest financial reports the company's total debt is NZ$1.80 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

Prestige Consumer Healthcare - Total debt on balance sheet (from 2004 to 2025)

Total debt by year

Year Total debt Change
2025-03-31NZ$1.84 B-3.26%
2024-03-31NZ$1.90 B-12.79%
2023-03-31NZ$2.18 B0.48%
2022-03-31NZ$2.17 B0.17%
2021-03-31NZ$2.16 B-26.94%
2020-03-31NZ$2.96 B12.63%
2019-03-31NZ$2.63 B-4.31%
2018-03-31NZ$2.75 B-11.94%
2017-03-31NZ$3.12 B33.19%
2016-03-31NZ$2.34 B11.99%
2015-03-31NZ$2.09 B94.72%
2014-03-31NZ$1.07 B-7.09%
2013-03-31NZ$1.15 B-15.34%
2012-03-31NZ$1.36 B113.88%
2011-03-31NZ$0.64 B39.77%
2010-03-31NZ$0.45 B-31.36%
2009-03-31NZ$0.66 B30.45%
2008-03-31NZ$0.51 B-21.01%
2007-03-31NZ$0.64 B-21.4%
2006-03-31NZ$0.82 B18.32%
2005-03-31NZ$0.69 B212.59%
2004-03-31NZ$0.22 B

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
GlaxoSmithKline
GSK
NZ$41.30 B 2,192.17%๐Ÿ‡ฌ๐Ÿ‡ง UK
Pfizer
PFE
NZ$105.32 B 5,745.04%๐Ÿ‡บ๐Ÿ‡ธ USA
Rite Aid
RAD
NZ$11.39 B 532.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
NZ$79.27 B 4,299.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Taro Pharmaceutical
TARO
NZ$3.37 M-99.81%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Novartis
NVS
NZ$55.43 B 2,976.02%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Procter & Gamble
PG
NZ$62.22 B 3,352.96%๐Ÿ‡บ๐Ÿ‡ธ USA
CVS Health
CVS
NZ$141.51 B 7,753.07%๐Ÿ‡บ๐Ÿ‡ธ USA
Clorox
CLX
NZ$5.32 B 195.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
NZ$22.40 B 1,143.11%๐Ÿ‡บ๐Ÿ‡ธ USA